Stroke Prevention and Anticoagulants (SPA) Case-Control Study to assess the relative risk of stroke in patients with Non-Valvular Atrial Fibrillation, taking dabigatran or other non-VKA oral anticoagulants (NOAC) compared with vitamin K antagonists
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 20 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management